Seeking Alpha


Send Message
View as an RSS Feed
Latest  |  Highest rated
  • Advanced Cell Technology And Dilution: Do We Really Have A Rational Choice? [View article]
    When the facts of the Ph. 1 AMD and SMD trials come out, all of this sturm und drang will be long forgotten and eigenman will be crying in his beer (unless he's keeping a core holding). Further, there is an even more exciting trial to come out soon and that is Cohort 2a, which are those with around 20/100 vision instead of 20/400 or worse vision. Thus, more rods and cones are still left and the RPE layer is not as decimated. I would not at all be surprised to find out that their vision was generally better than 20/40. Maybe even 20/20.

    Now, I have been in ACT since 2007. It has been hard but I believe in Lanza and the science. His current work with animals at Tufts will likely generate near term human trials on at least 8 different medical conditions that plague mankind. I have bought for years every year. IMHO, ACT/OCATA will become the 'stock of the century' and I just wish I were much younger to see it grow for 30 years or so. Not too likely for me. But great for mankind.

    BTW, if you want to get a glimpse of another future that is going to be so awesome (provided the Muslims have their own Reformation) get the book "The Second Machine Age" by Brynjolfsson and McAfee.

    By Christmas, we longs will all be smiling.

    Sep 29, 2014. 05:07 PM | 7 Likes Like |Link to Comment
  • Advanced Cell Tech's debtors want their money [View news story]
    There is an argument about the amount due. Since I'm not privy to the details, I don't know what the difference is. ACT paid what it thinks is the correct amount. I guess ACT will end up in court. Since ACT is strapped for cash, they probably have made decisions in their favor. Guess we'll see how it works out. Meanwhile, the two holders don't get shares in a company that is going to be worth many billions in the next few years. Here's the relevant paragraph from the 8k filed after the market closed.

    Item 8.01 Other Events

    The disclosure contained in Item 2.04 above is hereby incorporated by reference into this Item 8.01. On May 2, 2014 the Company paid to the Holders the Owed Amount, in an aggregate amount of approximately $1,616,000 calculated in accordance with the payment acceleration provisions of the Notes and satisfying the Company's obligations under the Notes. Upon the payment by the Company of the Owed Amount, the Company satisfied in full its obligations under the Notes and the terms of the Settlement Agreement and Mutual Release dated as of December 31, 2012 pursuant to which the Notes were issued in January 2013. The Company received correspondence from the Holders stating that the Holders believe the aggregate amount due to be different than the amount the Company paid. The Company believes that its interpretation of the Notes is accurate and complete.
    May 5, 2014. 05:09 PM | 5 Likes Like |Link to Comment
  • Senators introduce regenerative medicine bill [View news story]
    I'm just stunned that ACTC isn't mentioned above as being in the Regenerative Medicine "space". They are, unfortunately, in a news black out right now because they are publishing their interim TLD in a peer reviewed journal, which takes Toooooo long.

    However, their SMD and AMD results have been nothing short of stunning, as has leaked out. Their stem cell treatment regenerates the RPE layer of the eye and saves the rods and cones that would otherwise die. In a 'slip', Dr. Lanza, the genius behind ACTC, said one patient had moved from 20/400 to 20/40 and is able to drive again.

    So, whoever is responsible for keeping track had best broaden their net, imho.
    Mar 14, 2014. 03:23 PM | 5 Likes Like |Link to Comment
  • Advanced Cell Technology's CEO Discusses Q2 2013 Results - Earnings Call Transcript [View article]
    Anise is absolutely right. There will always be naysayers and doom talkers who vanish when the light of day shines brightly down on them. The Big Pharma folks just don't do much real risk taking outside of their own labs. They want to see results and ACT isn't talking yet. At least not enough for them to invest. The real danger to ACT is to get taken over in an unfriendly buyout and that would really screw the long time shareholders. I've been here since 2008, also, if I even remember correctly. My first 5,000 shares were bought at $0.85. And I've continued to buy as much as possible because this will be an incredible, revolutionary company in the next few years.

    My complaint about ACT is that they are caught up in the scientific paradigm of publishing in peer-reviewed journals as the way of announcing results rather than announcing results along. That sure worked great with the Lancet article. Yup. Great. (NOT) That means that no excitement and momentum is built until the Big Deal is announced. Which makes it tough to hang in unless you have done what Anise and others have done or are part of Ceasar's Palace at iCell where you get a wealth of information and strategic viewpoints. ACT will be the winner of this decade if not the century because of their science. Just hope they stay an independent company and don't get swallowed up by one of the Big Pharmas, which is not out of the question. Better buy a few hundred thousand shares at this price so you can retire wealthy in five years and not worry about Obamacare and the other idiocies of government. Wealth does that, you know?
    Aug 11, 2013. 01:30 AM | Likes Like |Link to Comment
  • Advanced Cell Technology Receives Approval from Data Safety Monitoring Board (DSMB) to Initiate Treatment of Third Patient Cohort in All Three Clinical Trials [View article]
    Very exciting because doing the 20/100 cohort rapidly without waiting interminably is now possible. I expect that these trials will result in immediate compassionate use designation and we'll be off to the races with a huge JV and up list to the Naz. jmho. Been here at least 6 years.
    Mar 15, 2013. 05:47 AM | Likes Like |Link to Comment
  • Europe Is Finished [View article]
    Yeah, I experienced that inflation. As a hard working (piling the neighbor's wood, shoveling snow, selling papers on a paper corner), thrifty 9 year old, and very patriotic, I bought $150 of War Bonds in 1946, which cost about $116.00. When I cashed them in, for college costs, in 1956, I did a little calculation and found I had lost $9 in purchasing power. Never, ever bought a US bond again.
    Nov 20, 2011. 04:40 AM | Likes Like |Link to Comment